Startups

Senior Director, Global SOX

Revolution Medicines · Redwood City, California, United States · On-site

← All jobs
About Revolution Medicines

Backed by GV.

About the role

RevMed is seeking an experienced, collaborative Senior Director, Global SOX to lead and scale the Company’s Sarbanes-Oxley compliance and internal controls program. This role has enterprise-wide governance responsibility for ICFR, ITGCs, ITACs, automated controls, key reports, and controls supporting evolving business processes, systems, commercial readiness, and global expansion.

What they're looking for

  • Lead RevMed’s global SOX and ICFR program, including annual planning, scoping, risk assessments, walkthroughs, documentation, testing coordination, deficiency evaluation, remediation tracking, and reporting
  • Develop a scalable operating model with centralized governance, consistent standards, clear accountability, and right-sized controls that maintain compliance without unnecessary operational burden
  • Maintain SOX documentation, including risk and control matrices, narratives, flowcharts, key reports, management review controls, and regional certifications or attestations
  • Provide quarterly and annual SOX updates to the Controller, senior management, and the Audit Committee, including status, key risks, deficiencies, and remediation progress
  • Oversee ITGC domains such as user access, privileged access, change management, SDLC, computer operations, interfaces, data integrity, cybersecurity dependencies, and third-party providers
  • Partner with IT, Information Security, system owners, and process owners to assess control implications of new systems, integrations, cross-border data flows, and significant configuration changes
More about this role

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

RevMed is seeking an experienced, collaborative Senior Director, Global SOX to lead and scale the Company’s Sarbanes-Oxley compliance and internal controls program. This role has enterprise-wide governance responsibility for ICFR, ITGCs, ITACs, automated controls, key reports, and controls supporting evolving business processes, systems, commercial readiness, and global expansion.

As a key...

Read the full posting on Revolution Medicines's site ↗

Corporate Accounting

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.